jamp efavirenz/emtricitabine/tenofovir disoproxil fumarate tablet
jamp pharma corporation - efavirenz; emtricitabine; tenofovir disoproxil fumarate - tablet - 600mg; 200mg; 300mg - efavirenz 600mg; emtricitabine 200mg; tenofovir disoproxil fumarate 300mg - nonnucleoside reverse transcriptase inhibitors
riva-efavirenz/emtricitabine/tenofovir tablet
laboratoire riva inc. - efavirenz; emtricitabine; tenofovir disoproxil fumarate - tablet - 600mg; 200mg; 300mg - efavirenz 600mg; emtricitabine 200mg; tenofovir disoproxil fumarate 300mg - nonnucleoside reverse transcriptase inhibitors
trivira film-coated tablet
saudi amarox, saudi arabia - efavirenz,tenofovir disoproxil,emtricitabine - film-coated tablet - 600,300,200 mg,
padviram 600 mg - 200 mg - 245 mg film-coat. tabl.
sandoz sa-nv - efavirenz 600 mg; emtricitabine 200 mg; tenofovir disoproxil succinate 300,6 mg - eq. tenofovir disoproxil 245 mg - film-coated tablet - emtricitabine, tenofovir disoproxil and efavirenz
atripla
gilead sciences pty ltd - emtricitabine; efavirenz; tenofovir disoproxil fumarate -
eviplera
gilead sciences pty ltd - tenofovir disoproxil fumarate; rilpivirine hydrochloride; emtricitabine -
atripla
gilead sciences (nz) - efavirenz 600mg; ; ; ; emtricitabine 200mg; ; ; ; tenofovir disoproxil fumarate 300mg; ; ; - film coated tablet - active: efavirenz 600mg emtricitabine 200mg tenofovir disoproxil fumarate 300mg excipient: croscarmellose sodium hyprolose magnesium stearate microcrystalline cellulose opadry pink 85f94172 purified water sodium laurilsulfate - atripla is indicated for the treatment of hiv infected adults over the age of 18 years, alone or in combination with other antiretroviral agents.
eviplera
gilead sciences (nz) - emtricitabine 200mg; ; ; ; rilpivirine hydrochloride 27.5mg equivalent to rilpivirine free base 25 mg; ; tenofovir disoproxil fumarate 300mg; ; ; - film coated tablet - active: emtricitabine 200mg rilpivirine hydrochloride 27.5mg equivalent to rilpivirine free base 25 mg tenofovir disoproxil fumarate 300mg excipient: croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose opadry polysorbate 20 povidone pregelatinised maize starch purified water - eviplera is indicated for the treatment of hiv infection in treatment-na?ve adult patients with plasma hiv-1 rna less than or equal to 100,000 copies/ml at the start of therapy. eviplera is also indicated in certain virologically-suppressed (hiv-1 rna <50 copies/ml) adult patients on a stable antiretroviral regimen at start of therapy in order to replace their current antiretroviral treatment regimen (see clinical trials). patients must not have a history of resistance to any of the components of eviplera (tenofovir df, emtricitabine or rilpivirine).
atripla
gilead sciences israel ltd - efavirenz; emtricitabine; tenofovir disoproxil as - film coated tablets - tenofovir disoproxil as 245 mg; emtricitabine 200 mg; efavirenz 600 mg - tenofovir disoproxil - tenofovir disoproxil - atripla is indicated for use alone as a complete regimen or in combination with other antiretroviral agents for the treatment of hiv-1 infection in adults.
efavirenz/emtricitabine/tenofovir disoproxil teva 600 mg/200 mg/245 mg film-coated tablets
teva b.v. - efavirenz; emtricitabine; tenofovir disoproxil - film-coated tablet - 600 mg/200 mg/245 milligram(s) - antivirals for treatment of hiv infections, combinations; emtricitabine, tenofovir disoproxil and efavirenz